These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC. Vaccine; 2008 May 02; 26(19):2307-13. PubMed ID: 18395947 [Abstract] [Full Text] [Related]
3. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W. Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677 [Abstract] [Full Text] [Related]
4. Development and use of fowlpox vectored vaccines for avian influenza. Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR. Ann N Y Acad Sci; 2006 Oct 29; 1081():193-201. PubMed ID: 17135511 [Abstract] [Full Text] [Related]
5. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Pavlova SP, Veits J, Mettenleiter TC, Fuchs W. Vaccine; 2009 Aug 13; 27(37):5085-90. PubMed ID: 19573638 [Abstract] [Full Text] [Related]
6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
11. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens. Sakabe S, Sakoda Y, Haraguchi Y, Isoda N, Soda K, Takakuwa H, Saijo K, Sawata A, Kume K, Hagiwara J, Tuchiya K, Lin Z, Sakamoto R, Imamura T, Sasaki T, Kokumai N, Kawaoka Y, Kida H. Vaccine; 2008 Apr 16; 26(17):2127-34. PubMed ID: 18346824 [Abstract] [Full Text] [Related]
14. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy. Kim SM, Kim YI, Park SJ, Kim EH, Kwon HI, Si YJ, Lee IW, Song MS, Choi YK. J Virol; 2017 Mar 15; 91(6):. PubMed ID: 28077631 [Abstract] [Full Text] [Related]
16. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H. Arch Virol; 2008 Mar 15; 153(9):1685-92. PubMed ID: 18651092 [Abstract] [Full Text] [Related]